Future studies are warranted to further decipher the mechanism(s) involved in epithelial DUOX1 expression and its relation to epithelial phenotype or development of EMT, which would allow for alternative approaches to therapeutically control DUOX1 expression as a potential treatment strategy in established lung cancer. The gene discussed is DUOX1; the disease is lung carcinoma.